|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02096 SIMCERE PHARMA
Nominal 
7.080 -0.040 (-0.562%) Ranking Overview
Ranking based on 6 research report(s)
Average Ranking 2.00
|
Strong Buy (1)
0
|
Buy (2)
6
|
Hold (3)
0
|
Sell (4)
0
|
Strong Sell (5)
0
|
Previous Financial Performance
| Financial Year | 12/2023 | EPS | 27.00 RMB (cts) | |
| Net Profit | 714.76 RMB (MIL) | DPS | 16.00 RMB (cts) |
Consolidation Estimation
| Financial Year | Profit / (Loss) (RMB (MIL)) |
EPS/ ((LPS)(RMB (cts)) |
DPS (RMB (cts)) |
Net Asset Value per Share (RMB) |
Highest (RMB (MIL)) |
Lowest (RMB (MIL)) |
| 2024 | 924.00 | 36.00 | 15.79 | -- | 1,029.00 | 881.00 |
| 2025 | 1,226.00 | 47.50 | 18.12 | -- | 1,373.00 | 1,098.00 |
| 2026 | 1,486.00 | 57.00 | 19.71 | -- | 1,781.00 | 1,367.00 |
Profit Estimation
| Profit Estimation | Profit / (Loss) (RMB (MIL)) |
EPS*/ (LPS) (RMB (cts)) |
DPS * (RMB (cts)) |
Broker | Ranking | Target Price* (HKD) |
Update Date | |
| 2024 | 931.00 | 36.00 | -- | BOCOM | Buy | 10.00 | 23/08/2024 | |
| 2024 | 909.00 | 36.00 | -- | CITIC SEC | Buy | 9.90 | 11/09/2024 | |
| 2024 | 958.36 | 37.00 | 18.37 | HUATAI FIN HLDGS HK | Buy | 8.81 | 22/08/2024 | |
| 2024 | 881.00 | 35.00 | 14.00 | CICC | OutPerform | 8.80 | 26/10/2024 | |
| 2024 | 1,029.00 | 37.00 | -- | MORGAN STANLEY | Overweight | 8.50 | 31/07/2024 | |
| 2024 | 917.00 | 35.00 | 17.58 | UBS | Buy | 8.20 | 31/05/2024 | |
| 2025 | 1,098.00 | 43.20 | -- | BOCOM | -- | -- | 23/08/2024 | |
| 2025 | 1,257.00 | 50.00 | -- | CITIC SEC | -- | -- | 11/09/2024 | |
| 2025 | 1,373.00 | 53.00 | 26.33 | HUATAI FIN HLDGS HK | -- | -- | 22/08/2024 | |
| 2025 | 1,142.00 | 45.00 | 16.00 | CICC | -- | -- | 26/10/2024 | |
| 2025 | 1,331.00 | 49.00 | -- | MORGAN STANLEY | -- | -- | 31/07/2024 | |
| 2025 | 1,195.00 | 46.00 | 20.24 | UBS | -- | -- | 31/05/2024 | |
| 2026 | 1,367.00 | 53.70 | -- | BOCOM | -- | -- | 23/08/2024 | |
| 2026 | 1,486.00 | 59.00 | -- | CITIC SEC | -- | -- | 11/09/2024 | |
| 2026 | 1,781.00 | 68.00 | 34.15 | HUATAI FIN HLDGS HK | -- | -- | 22/08/2024 | |
| 2026 | 1,570.00 | 57.00 | -- | MORGAN STANLEY | -- | -- | 31/07/2024 | |
| 2026 | 1,415.00 | 54.00 | 19.71 | UBS | -- | -- | 31/05/2024 | |
| Remarks: | Average rating ranges from 1 to 5. The lower the figure, the higher the rating and the vice versa. |
| *EPS, DPS and Estimated Price would be adjusted upon Consolidation, Split and Bonus Issue | |
| Real time quote last updated: 15/11/2024 17:59 | |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 456,600 |
| %Change | -79.918% |
| EPS / (LPS) | RMB 0.180 |
| NBV Per Share (¥) | RMB 2.716 |